Severe hypertriglyceridemia associated with everolimus drug-eluting stent placement in an infant

2019 ◽  
Vol 29 (4) ◽  
pp. 541-543 ◽  
Author(s):  
Kuan-Chi Lai ◽  
Julie A. Brothers ◽  
Jason Z. Stoller
Keyword(s):  
Pulmonary Vein ◽  
Current Literature ◽  
Stent Placement ◽  
Serum Triglyceride ◽  
Pulmonary Vein Stenosis ◽  
Drug Eluting Stents ◽  
Drug Eluting Stent ◽  
Severe Hypertriglyceridemia ◽  
Drug Eluting ◽  
Vein Stenosis

AbstractWe report a case of severe hypertriglyceridemia associated with an everolimus drug-eluting stent in an infant with pulmonary vein stenosis. We review from current literature the mechanisms by which everolimus may cause dyslipidaemia, pharmacokinetics of everolimus in drug-eluting stents, and treatments of hypertriglyceridemia. This case demonstrates the need to closely monitor serum triglyceride levels after everolimus drug-eluting stent placement in infants.

scholarly journals Clinical outcomes after the endovascular treatments of pulmonary vein stenosis in patients with congenital heart disease

2019 ◽  
Vol 29 (8) ◽  
pp. 1057-1065 ◽  
Author(s):  
Yoshihiko Kurita ◽  
Kenji Baba ◽  
Maiko Kondo ◽  
Takahiro Eitoku ◽  
Shingo Kasahara ◽  
...  
Keyword(s):  
Pulmonary Vein ◽  
Stent Implantation ◽  
Bare Metal Stent ◽  
Pulmonary Vein Stenosis ◽  
Drug Eluting Stent ◽  
Bare Metal ◽  
Metal Stent ◽  
Significant Difference ◽  
Drug Eluting ◽  
Vein Stenosis

AbstractBackground:Pulmonary vein stenosis (PVS) is a condition with challenging treatment and leads to severe cardiac failure and pulmonary hypertension. Despite aggressive surgical or catheter-based intervention, the prognosis of PVS is unsatisfactory. This study aimed to assess the prognosis and to establish appropriate treatment strategies.Methods:We retrospectively reviewed endovascular treatments for PVS (2001–2017) from the clinical database at the Okayama University Hospital.Results:A total of 24 patients underwent PVS associated with total anomalous pulmonary venous connection and 7 patients underwent isolated congenital PVS. In total, 53 stenotic pulmonary veins were subjected to endovascular treatments; 40 of them were stented by hybrid (29) and percutaneous procedures (11) (bare-metal stent, n = 34; drug-eluting stent, n = 9). Stent size of hybrid stenting was larger than percutaneous stenting. Median follow-up duration from the onset of PVS was 24 months (4–134 months). Survival rate was 71 and 49% at 1 and 5 years, respectively. There was no statistically significant difference between stent placement and survival; however, patients who underwent bare-metal stent implantation had statistically better survival than those who underwent drug-eluting stent implantation or balloon angioplasty. Early onset of stenosis, timing of stenting, and small vessel diameter of pulmonary vein before stenting were considered as risk factors for in-stent restenosis. Freedom from re-intervention was 50 and 26% at 1 and 2 years.Conclusions:To improve survival and stent patency, implantation of large stent is important. However, re-intervention after stenting is also significant to obtain good outcome.

scholarly journals Drug-eluting stents for the treatment of pulmonary vein stenosis after atrial fibrillation ablation

EP Europace ◽  
2010 ◽  
Vol 13 (1) ◽  
pp. 57-61 ◽  
Author(s):  
T. J. R. De Potter ◽  
B. Schmidt ◽  
K. R. J. Chun ◽  
C. Schneider ◽  
R. Malisius ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Pulmonary Vein ◽  
Atrial Fibrillation Ablation ◽  
Pulmonary Vein Stenosis ◽  
Drug Eluting Stents ◽  
Drug Eluting ◽  
Vein Stenosis

scholarly journals OUTCOMES AFTER IMPLANTATION OF BARE-METAL, COVERED AND DRUG-ELUTING STENTS FOR THE TREATMENT OF PULMONARY VEIN STENOSIS IN CHILDREN

2011 ◽  
Vol 57 (14) ◽  
pp. E2007
Author(s):  
Sowmya Balasubramanian ◽  
Audrey C. Marshall ◽  
Lynn F. Peng ◽  
James E. Lock ◽  
Doff B. McElhinney
Keyword(s):  
Pulmonary Vein ◽  
Pulmonary Vein Stenosis ◽  
Drug Eluting Stents ◽  
Bare Metal ◽  
Drug Eluting ◽  
Vein Stenosis

Pulmonary vein stenosis with collateralization via esophageal varices: Long-term follow-up after successful treatment with drug-eluting stent

2017 ◽  
Vol 13 (1) ◽  
pp. 124-130 ◽  
Author(s):  
Jason F. Goldberg ◽  
Craig L. Jensen ◽  
Rajesh Krishnamurthy ◽  
Nidhy P. Varghese ◽  
Henri Justino
Keyword(s):  
Pulmonary Vein ◽  
Successful Treatment ◽  
Esophageal Varices ◽  
Pulmonary Vein Stenosis ◽  
Drug Eluting Stent ◽  
Long Term Follow Up ◽  
Drug Eluting ◽  
Vein Stenosis

The first reported case of pulmonary vein stenosis treated by percutaneous angioplasty with self-apposing drug-eluting stent implantation

2015 ◽  
Vol 179 ◽  
pp. 13-15
Author(s):  
Maksymilian Mielczarek ◽  
Dariusz Ciecwierz ◽  
Robert Sabiniewicz ◽  
Anna Kochanska ◽  
Justyna Suchecka ◽  
...  
Keyword(s):  
Pulmonary Vein ◽  
Stent Implantation ◽  
Pulmonary Vein Stenosis ◽  
Drug Eluting Stent ◽  
Percutaneous Angioplasty ◽  
Drug Eluting ◽  
Vein Stenosis

“Half-uncovered technique” to secure larger stents for postoperative pulmonary vein stenosis

2021 ◽  
pp. 1-3
Author(s):  
Hiroaki Kise ◽  
Takanari Fujii ◽  
Hideshi Tomita
Keyword(s):  
Pulmonary Vein ◽  
Stent Placement ◽  
Pulmonary Vein Stenosis ◽  
Vein Stenosis ◽  
Stenotic Lesions

Abstract Although larger stent placement could be effective for pulmonary vein stenosis, stents extrusion tends to occur due to caliber narrowing, small landing area, and the slippery nature. We placed stents with diameter ≧8 mm for four stenotic lesions using the “half-uncovered technique”. All stents were precisely placed and successfully resolved the stenosis. This technique allows us to avoid extrusion and to perform safe and effective dilatation when placing larger stents for pulmonary vein stenosis.

Sign in / Sign up

Export Citation Format

Share Document